Genomic disorders manifesting during childhood are distinct in terms of clinical spectrum and genetic etiology. The clinical application of genomic technologies and interpretation of genomic results require careful and unique considerations. In this session, the two speakers will describe the current state of the application of clinical genome-scale technologies to childhood Mendelian disorders and pediatric cancers.
The Current State of the Field in Pediatric Cancer Genomics and Rare Disorders
Sharon E. Plon, MD, PhD, Baylor College of Medicine, Houston, TX, USA
Utility of WGS in Molecular Analysis Pediatric Cancers Discussing the Pro’s and Con’s Within the
Question of Clinical Utility
Jinghui Zhang, PhD, St. Jude Children's Research Hospital, Memphis, TN, USA
Objectives:
- Choose correct genome-scale technology and test for the different clinical applications
- Explain the different types of genomic technologies and the different variants reported with such technologies.
- Define the evidence for the correct classification of germline variants.
Recording Date: November 19, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.50 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
